R. Doyle Stulting
Emory University
184 Papers
1.5K Citations
R. Doyle Stulting is an academic researcher from Emory University. The author has contributed to research in topics: Medicine & LASIK. The author has an hindex of 51, co-authored 177 publications. Previous affiliations of R. Doyle Stulting include Allergan.
Chat about Author
Papers
Risk assessment for ectasia after corneal refractive surgery.
TL;DR: A quantitative method can be used to identify eyes at risk for developing ectasia after LASIK that, if validated, represents a significant improvement over current screening strategies.
713
Risk factors and prognosis for corneal ectasia after LASIK
TL;DR: Retrospective review of preoperative and postoperative data for each case compared with that of previously reported cases and cases with uneventful postoperative courses found significant risk factors for the development of ectasia after LASIK include high myopia, forme fruste keratoconus, and low RSB.
630
Risk Factors for Corneal Graft Failure and Rejection in the Collaborative Corneal Transplantation Studies
Maureen G. Maguire,Walter J. Stark,John D. Gottsch,R. Doyle Stulting,Alan Sugar,Nancy E. Fink,Ann E Schwartz +6 more
TL;DR: Risk of graft failure varies substantially, even within a high-risk population, and the number of risk factors present should be considered by the patient and surgeon when contemplating transplantation and planning follow-up.
469
Dissatisfaction after multifocal intraocular lens implantation.
TL;DR: Complaints of blurred vision and photic phenomena after multifocal IOL implantation were effectively managed with appropriate treatment and should be delayed until it has been determined that IOL exchange will not be necessary.
432
Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease
Kirk R. Wilhelmus,Roy W. Beck,Pamela S. Moke,Chandler R. Dawson,Bruce Barron,Daniel B. Jones,Herbert E. Kaufman,Natalie Kurinij,R. Doyle Stulting,Joel Sugar,Elisabeth J. Cohen,Robert A. Hyndiuk,Penny A. Asbell +12 more
TL;DR: 12 months of treatment with acyclovir reduces the rate of recurrent ocular HSV disease and orofacial HSV diseases and is most important for patients with a history of HSV stromal keratitis, since it can prevent additional episodes and potential loss of vision.
348